HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Array-CGH characterization of a prenatally detected de novo 46,X,der(Y)t(X;Y)(p22.3;q11.2) in a male fetus.

Abstract
We report on an apparently normal 5-month-old boy with a X;Y complex rearrangement identified first on prenatal diagnosis and found on array-CGH to have a 7.6 Mb duplication of Xp22.3 chromosome and a deletion of Yq chromosome, distal to the AZFa locus. Karyotype analysis on amniotic fluid cell cultures revealed a de novo homogenous chromosome marker that we interpreted as an isochromosome Yp. FISH analysis using SRY probe revealed only one signal on the derivative Y chromosome. The final karyotype was interpreted as 46,X,der(Y)t(X;Y)(p22.31;q11.22). Translocation Xp22;Yq11 in male are very rare event and only 4 cases have been published, all showing mental retardation and malformations. Herein we discussed some possible explanation for this apparent phenotypic variability.
AuthorsChiara Palka, Melissa Alfonsi, Elisena Morizio, Alessandra Soranno, Daniela La Rovere, Barbara Matarrelli, Anna Lucia Rullo, Roberto Zori, Francesco Chiarelli, Giuseppe Calabrese
JournalEuropean journal of medical genetics (Eur J Med Genet) 2011 May-Jun Vol. 54 Issue 3 Pg. 333-6 ISSN: 1878-0849 [Electronic] Netherlands
PMID21354345 (Publication Type: Case Reports, Journal Article)
CopyrightCopyright © 2011 Elsevier Masson SAS. All rights reserved.
Topics
  • Adult
  • Chromosome Banding
  • Chromosomes, Human, X (genetics)
  • Chromosomes, Human, Y (genetics)
  • Comparative Genomic Hybridization (methods)
  • Female
  • Fetal Diseases (diagnosis, genetics)
  • Humans
  • In Situ Hybridization, Fluorescence
  • Infant
  • Karyotyping
  • Male
  • Pregnancy
  • Pregnancy Outcome
  • Prenatal Diagnosis (methods)
  • Translocation, Genetic

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: